Kibel, Adam S <br/><br/>
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.  [electronic resource] 

 -  The Journal of urology  May 2007 
 - 1777-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/j.juro.2007.01.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Docetaxel<br/>Drug Administration Schedule<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--blood<br/>Pilot Projects<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy<br/>Prostatic Neoplasms--drug therapy<br/>Radiation-Sensitizing Agents<br/>Risk Factors<br/>Survival Rate--trends<br/>Taxoids--administration & dosage<br/>Treatment Outcome